Johnson & Johnson's most recent trend suggests a bullish bias. One trading opportunity on Johnson & Johnson is a Bull Put Spread using a strike $170.00 short put and a strike $165.00 long put offers a potential 10.38% return on risk over the next 14 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $170.00 by expiration. The full premium credit of $0.47 would be kept by the premium seller. The risk of $4.53 would be incurred if the stock dropped below the $165.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Johnson & Johnson is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Johnson & Johnson is bullish.
The RSI indicator is at 72.7 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Johnson & Johnson
Earnings Report Roundup
Wed, 04 Aug 2021 21:16:00 +0000
Here's a look at the latest earnings in the market and a chat with “Wall Street Journal” reporter Eliot Brown.
Moderna (MRNA) Option Traders Ready for Earnings Boost
Wed, 04 Aug 2021 19:07:39 +0000
A sizable number of purchased call options and sold put options remain the open interest for MRNA, and option premiums are unusually high right now.
10 Best Dividend Stocks to Buy in August
Wed, 04 Aug 2021 18:43:04 +0000
In this article, we will be looking at the 10 best dividend stocks to buy in August. If you want to skip our detailed analysis of these stocks, you can go directly to see the 5 Best Dividend Stocks to Buy in August. Dividend stocks are among the more versatile investment options available to investors […]
Music events like Lollapalooza are not safe right now: Doctor
Wed, 04 Aug 2021 18:12:15 +0000
Dr. Ali Raja, Professor at Harvard Medical School, joins Yahoo Finance to the latest on the coronavirus pandemic.
Is JNJ Stock A Buy Or A Sell As Delta Question Plagues Covid Shot?
Wed, 04 Aug 2021 16:58:04 +0000
Is JNJ stock a buy or a sell as questions continued to plague its Covid vaccine in July and JNJ stock remained rangebound?
Also on Market Tamer…
Follow Us on Facebook